Skip to main content

Table 2 Baseline characteristics of patients excluded due to any reasona

From: Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

 

All excluded patients

Characteristic

Memantine

( n = 156)

Placebo

( n = 171)

Female

91 (58.3)

92 (53.8)

Age, mean (SD) years

75.4 (7.3)

75.7 (8.7)

Caucasian

147 (94.2)

162 (94.7)

Black

4 (2.6)

3 (1.8)

Asian

0 (0.0)

1 (0.6)

Other

5 (3.2)

5 (2.9)

MMSE score, mean (SD)

17.9 (4.0)

18.0 (3.6)

  1. Data are number (%) unless otherwise specified. aExclusion criteria were mild Alzheimer's disease (MMSE ≥ 20 at baseline), receiving a cholinesterase inhibitor other than donepezil, or receiving donepezil at a dose < 10 mg/day. MMSE, Mini-Mental State Examination.